HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nu Skin plans ageLOC expansion

This article was originally published in The Rose Sheet

Executive Summary

Firm plans to extend its ageLOC offering with introduction of "an unmatched daily skin-care system" this October, according to June 22 release. A nutritional supplement will follow in the second half of 2010, Nu Skin says. Galvanic Spa Facial Gels with ageLOC technology, which targets a "source of internal aging [that] is capable of generating free radicals in the epidermis around the clock," launched in fall 2008. Announcement emerges from firm's international sales meeting in Saint Petersburg, Russia. "AgeLOC will not only have significant implications for an aging population that wants to live young, but also for an increasing number of people who are seeking out Nu Skin's business opportunity to supplement or replace their income," company says. With more than 750,000 independent sales reps in 48 international markets, direct seller notes that its distribution program is an "attractive option" for many in the current economy. By 2030, the world's population of people over the age of 60 is expected to double to more than 1 billion, according to Nu Skin, which "believe[s] that ageLOC is unlocking the secret of youth.

You may also be interested in...



Nu Skin enters research agreements

Direct seller of anti-aging products has entered into research agreements with Stanford University and Madison, Wis.-based LifeGen Technologies to improve its understanding of the genetic basis of aging. In an Oct. 22 release, the firm says its agreement with Stanford "aims to increase the understanding of fundamental aging mechanisms" and includes access to the university's expertise in dermatological clinical trials. The exclusive agreement with LifeGen will "leverage LifeGen's proprietary methods regarding gene expression profiling and pathways affected by aging." The relationships will "help us develop next-generation skin care and nutritional products," says Joseph Chang, Nu Skin chief scientific officer and executive VP of product development. Provo, Utah-based Nu Skin sells its personal-care products - including cosmetics, hair care and fragrances - in 48 international markets through more than 750,000 independent sales representatives. In 2010, it plans to expand its ageLOC anti-aging line with nutritional supplements (1"The Rose Sheet" June 29, 2009)

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

UsernamePublicRestriction

Register

RS016251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel